Stay updated on Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-02-24T05:43:21.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The website has updated to revision v2.14.2, noting that some NLM-NCBI services are experiencing heavy traffic, which may impact performance and availability.
    Difference
    0.6%
    Check dated 2025-02-05T19:39:54.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-22T13:06:16.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-08T02:46:30.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-17T13:47:55.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for inquiries about joining the study and includes a reference to the Contacts and Locations section in the How to Read a Study Record.
    Difference
    1.0%
    Check dated 2024-12-10T09:33:49.000Z thumbnail image

Stay in the know with updates to Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.